Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS3872867 A
Publication typeGrant
Publication dateMar 25, 1975
Filing dateMay 9, 1973
Priority dateJun 2, 1971
Publication numberUS 3872867 A, US 3872867A, US-A-3872867, US3872867 A, US3872867A
InventorsKillinger Fred M
Original AssigneeUpjohn Co
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Wet-dry additive assembly
US 3872867 A
Abstract
A pair of vials each having a perforable seal closing an opening in one end thereof and a hollow cylindrical portion of reduced diameter adjacent the seal. A double-ended cannula is slidably receivable into the reduced end portions of the vials for perforating the seals to communicate with and between the interiors of the vials. A support on the cannula is removably engageable with the reduced portion on one of the vials. An elongated tubular sheath extends between and is slidably supported upon the cannula support and upon both of the vials.
Images(1)
Previous page
Next page
Claims  available in
Description  (OCR text may contain errors)

llnited States Patent [1 1 ltillinger [111 3,872,867 Mar. 25, 1975 WET-DRY ADDITIVE ASSEMBLY Inventor: Fred M. Killinger, Portage, Mich.

The Upjohn Company, Kalamazoo, Mich.

Filed: May 9, 1973 Appl. No.: 358,693

Related U.S. Application Data Continuation-in-part of Ser. No. 149,321, June 2, 1971, Pat. No. 3,788,369, Continuation-impart of Ser. No. 212,592, Dec. 27, 1971, Pat. No. 3,826,260.

Assignee:

U.S. Cl 128/272, 206/219, 128/DIG. 28 Int. Cl. A6lj 1/00 Field of Search 128/D1G. 28, 272, 218 M, 128/218 NV, 218 R, 218 N, 215, 216, 221, 218 D, 218 DA References Cited UNITED STATES PATENTS 3/1961 Murrish 128/272 8/1967 Sarnoff et a1 128/218 M 2/1968 Hassing et al 128/221 3,375,825 2/1968 Keller 128/221 3,392,726 7/1968 Pochyla et al 128/218 M X 3,563,373 2/1971 Paulson 128/218 M X 3,659,602 5/1972 Cloyd 128/220 Primary Examiner-Richard A. Gaudet Assistant Examiner-J. C. McGowan Attorney, Agent, or Firm-Woodhams, Blanchard and Flynn [57] ABSTRACT 4 Claims, 5 Drawing Figures WET-DRY ADDITIVE ASSEMBLY This application is a Continuation-in-Part of patent applications Ser. No. 149,321, filed June-2, 1971, now U.S. Pat. No. 3,788,369 and entitled APPARATUS FOR TRANSFERRING LIQUID BETWEEN A CON- TAINER AND A FLEXIBLE BAG, and Ser. No. 212,592, filed Dec. 27, 1971, now US. Pat. No. 3,826,260 entitled VIAL AND SYRINGE COMBI- NATION.

BACKGROUND OF THE INVENTION This invention relates in general to a device for storing and supplying additives or'medicaments and, more particularly, to a type thereof including one sealed vial holding a diluent, another sealed vial holding an additive or medicament and interconnecting means for holding the vials together and for effecting selective communication between said vials, whereby said diluent can be mixed with said additive and thereafter fed into a passageway, such as a tube connected to a patient by a cannula for intravenous feeding.

Persons familiar with the preparation and use of pa renteral. additives or medicaments have long been aware of the fact that certain, additives, for example, tend to loose their effectiveness rather soon after they are mixed with a diluent in preparation for administration. Thus, they must be stored in a dry or non-liquid condition and then mixed with a diluent, preferably just before the additive is supplied, for example, to an intravenous bottle.

In the past, it has been common practice to furnish separate vials of dry additive and diluent and to use a conventional syringe for transferring the diluent from one vial to another for the purpose of mixing the two in order to administer the additive. This arrangement involves the risk of contamination, the risk of improper dose and even the risk of mixing the wrong ingredients where the administration .of additive must be handled by unskilled persons.

Numerous attempts have been made to solve the foregoing problems as by furnishing syringes and vials connected together so that the supply and administration means are part of a package which is more readily usable. However, the previous combinations or packages involving an additive and a diluent have not proven satisfactory, heretofore, for a variety of reasons. For example, they have not satisfactorily avoided contamination, they have been too delicate for conventional storing and handling procedures, they have been too susceptible to accidental actuation whereby the materials are mixed too soon, and in general they have been almost as complicated and delicate to operate as the devices which they were intended to replace.

Accordingly, a primary object of this invention is the provision of a double vial assembly with a connecting structure between the vials whereby the sterility of the diluent and the additive or medicament in the vials is maintained prior to and during the mixing of the diluent with the additive and, at the same time, the cannula for the administration of the solution is shielded from contamination during the mixing and up to the very moment of insertion into the intravenous system or bottle.

A further object of this invention is the provision of a double vial assembly, as aforesaid, in which injectable additives or medicaments can be safely stored for relatively long periods of time, as in drug stores, clinics and doctors offices, along with a suitable diluent in a single package capable of mixing the diluent, and additive without any likelihood of contaminating the needle, the diluent or the additive.

A further object of this invention is the provision of an assembly, as aforesaid, which is rugged so that it cannot be readily damaged during shipment or storage, which is constructed so that accidental mixing of the diluent and the additive is positively opposed and, yet, wherein intentional mixing of the additive and the diluent can be effected safely, easily and quickly in preparation for supplying of the solution. by any person capable of following simple instructions.

Other objects and purposes of this invention will bei FIG. 5 is a fragment of FIG. 2 showinga modified structure; a

For convenience in description, the terms upper, lower and words of similar import will have reference to the double vial assembly or parts thereof as appearing in FIGS. 1 and 2. The terms inner, outer and derivatives thereof will have reference to the geometric center of the assembly and major components thereof. I

SUMMARY OF THE INVENTION The objects and purposes of the invention, including those set forth above, have been met by providing an assembly including one sealed vial containing a diluent, another sealed vial containing an. additive or medicament, which may be liquid or dry, and a connection structure that includes a sheath and a cannula which extend between and are supported upon the sealed ends of the two vials. The connection structure is arranged so that the sharpened ends of the cannula can be held spaced from, or slightly embedded in, the seals over the open ends of the vials. By effecting relative movement of the vials toward each other, the cannula pierces the seals and thereby communicates with and between the interiors of the vials. The additive vial is under vacuum or the diluent vial is pressurized to effect movement of the diluent from its vial through the cannula into the additive vial after which the additive is dissolved in the diluent by gently shaking the assembly. The diluent vial and sheath are now removed from the assembly so that the cannula is exposed and cube injected into an intravenous system of bottle whichis also undervacuum.

DETAILED DESCRIPTION The double vial assembly 10 (FIGS. 1 and 2) is comprised of a vial 11 connected to a similar or identical vial 12 by an intermediate structure 13. The vial 11 has a chamber 16, and the lower open mouth portion 18 thereof is of reduced diameter and is covered by a seal 19 which may be a resilient, flanged stopper. The seal is held in place by the integral enlarged portion 22 of the sleeve 23 which is preferably fabricated from metal. The sleeve 23 has a shoulder 24 which forms part of the enlarged portion 22 and presses the flange 25 of the seal 19 firmly against the lower end of the vial 16.

The vial 12 has an open mouth 36 which is covered by a seal, such as the flanged stopper 37, which is in turn held in place by the enlarged lower portion 38 of the sleeve 39. That is, the sleeve 39 has an integral shoulder 42 which bears downwardly against the flange of the stopper 37 thereby holding it tightly against the upper end 36 of the vial 12.

A cannula 26, which is sharpened on both ends, has a hub 27 rigidly secured thereto and spaced from both ends thereof. A tubular cannula support 28 has one end thereof secured to the hub 27 which it concentrically encircles. The remainder of the tubular support 28 is spaced radially outwardly from the cannula and projects toward the lower end thereof. The tubular support 28 has an integral flange 29 at its lower end. The hub 27. may be made from metal or plastic and the tubular support 28 is preferably fabricated from plastic. In some circumstances, the hu b 27 may be integral with and part of the tubular support 28.

The upper end portion of the sleeve 39 (FIG. 4) and the lower portion of the tubular support 28 have interferring deformations, such as annular ridges 32 and 33, respectively, by which the spaced relationship between the lower. end of the cannula 26 and the seal 37 is determined. This spaced position is shown in FIG. 2. By moving the tubular support28, hence the cannula 26, downwardly, the ridge 33 on the tubular support 28 is moved downwardly from between the two uppermost ridges 32 on the sleeve 23 until said ridge 33 moves past the lowermost ridge 32A, during which the seal 37 is penetrated by the cannula 26. The ridge 32A and the ridge 33 hold the cannula in the penetrating position.

A substantially cylindrical sheath 43 (FIG. 4) extends from the enlarged portion 22 of sleeve 23 to the enlarged portion 38 of sleeve 39. Said sheath 43 has a central cylindrical opening 44 the lower portion of which is sleeved snugly but slidably upon the tubular support 28. Said sheath has a lower enlarged opening 46 with an inside diameter approximately equal to the outside diameter of the enlarged portion 38 of sleeve 39. Said lower opening 46 is also slightly larger than the flange 29. at the lower end of the tubular support 28. Thus, as the sheath 43 is moved downwardly relative to the vial 12, the engagement between the flange 29 and the shoulder 47 at the upper end of the lower opening 46 act to move the tubular support 28, hence the cannula 26, downwardly with the sheath 43. At the same time, the enlarged portion 38 is slidably received upwardly into the opening 46 in snug engagement with the lower part of sheath 43 defining the peripheral wall of the opening 46.

A flanged sleeve 45 is snugly disposed in the upper end of the central opening 44 (FIG. 3). Said sleeve has an annular ridge 48 which coacts with annular ridges 49 on the sleeve 23. In this case, there are three ridges 49, two near the lower end of the sleeve and one near the upper end. The ridge 48 is located between the ridges 49 when the upper end of the cannula 29 is spaced from, or at least is not penetrating through, the stopper 19. The sheath 43 can be moved upwardly relative to the sleeve 23 into a position where the ridge 48 is above the uppermost ridge 49A, at which time the cannula 26 penetrates completely through the stopper 19. Also, during this movement, the enlarged portion 22 on the sleeve 23 is slidably but snugly moved downwardly into the enlarged opening 52 at the upper end of the sheath 43 and coaxial with the central opening 44.

OPERATION The operation of the double vial assembly (FIG. 1), to which this application applies, will be apparent to skilled persons upon reading the foregoing description. However, for convenience, such operation will now be summarized briefly.

In preparation, the vial 12 will be filled with a medicament, which may be a liquid or a dry powdery material produced by evaporative procedures, and the pressure in the vial 12 will preferably be reduced (that is, less than atmospheric). The stopper 37, which is held in place by the sleeve 39, will be unperforated, and the vial 11 may be pressurized.

The vial 11 will contain a liquid and the sleeve 23 (FIG. 2) will hold theseal 19, which is also unperforated. The cannula support 28, which is secured tothe cannula 26 through the hub 27, will be mounted upon the upper end of the sleeve 39 so that the ridge 33 near the lower end of the interior wall of the tubular support 28 is located between the two ridges 32 near the upper end of the sleeve 39. In this position, the cannula will be spaced from the seal 37.

The sheath 43 is now sleeved downwardly over the cannula 26 at the tubular support 28 until the shoulder 47 engages the flange 29. At the same time, the lower end 46 of the sheath 43 will preferably slightly overlap the enlarged portion 38 of the sleeve 39, which portion 38 surround the vial mouth 36. The sheath 43 and vial 12 can now be simultaneously manually engaged in one hand while the vial 12 is engaged in the other hand and the sleeve 23 on the vial 11 is slidably inserted first into the enlarged opening 52 at the upper end of the sheath and then into the sleeve 45 in the upper end of the centralopening 44. This sliding connection will be terminated when-the ridge 48 on the wall-defining the opening through the sleeve 45 is located between the ridges 49 on the sleeve 23. At this time, theupper end of the sheath 43 will be preferably telescoped slightly over the vial mouth 18, as by engaging the enlarged portion 22 of the sleeve 23.

The assembly 10 is now in condition for shipment and/or storage as long as desired. While the diluent has been disclosed in the upper vial 11 and the medicament in the lower vial 12, this situation can be reversed. Also, it will be seen that the flanged sleeve 45 can be an integral part of the sheath 43.

When it becomes desirable to administer the medicament in the vial 12, the two vials 11 and 12 are either simultaneously or sequentially urged toward the sheath so that the cannula perforates and extends completely through the seals 19 and 37, thereby communicating with and between the chambers within the two vials. The diluent in vial 11 will now move downwardly due to the differential pressure through the cannula into the vial 12.

By a gentle shaking action, the powdered or liquid material within the lower vial 12 is mixed with the diluent from the upper vial 11. If the mixed diluent and additive must be administered at once, the sheath 43 and vial l1 are moved upwardly away from the vial 12 and the tubular cannula support 28 so that the upper end of the cannula 26 is exposed. The cannula will remain in position with respect to the vial 12 due to the interengagement of the ridges on the sleeve 39 with the ridge on the tubular support 28. That is, ridge 33 will be under the ridge 32A and the upper ridges 32 may be somewhat embedded in the interior wall of the tubular support 28. The cannula 26 is inserted downwardly into an intravenous bottle, for example, in which the pressure is reduced so that the liquified additive is withdrawn from the vial 12 through the cannula 26 and into the l.V. bottle.

In a modified construction, the stopper 37 of FlG. 3 may be replaced by the stopper 56 (FIG. 5) having an upward extension 57 into which the lower end of cannula 26 is embedded to seal the end thereof.

Although particular preferred embodiments of the invention have been disclosed in detail for illustrative purposes, it will be recognized that variations or modifications of the disclosed apparatus, including the rearrangement of parts, lie within the scope of the present invention.

The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows:

l. A double vial assembly for storing a medicament, comprising:

first vial means defining a chamber therein and having a first elongated sleevelike end portion of reduced diameter, said first sleevelike end portion having a first flow opening therethrough for providing the only communication with said chamber;

perforable seal means blocking said first opening, said seal means being spaced inwardly from the outer end of said first opening as defined adjacent the free end of said first sleevelike end portion;

second vial means defining a chamber therein and having a second elongated sleevelike end portion of reduced diameter, said second sleevelike end portion having a second flow opening therethrough for providing the only communication with said chamber in said second vial means;

perforable stopper means blocking said second flow opening, said perforable stopper means being spaced inwardly of said second sleevelike opening from the outer end thereof as defined adjacent the free end of said second end portion;

elongated double ended cannula means extending between said first and second vial means, said cannula means having one end portion thereof loosely but slidably disposed within said first sleevelike end portion, the other end portion of said cannula means being loosely but slidably disposed within said second sleevelike end portion;

support means disposed in surrounding relationship to said cannula means and fixedly secured thereto at a location disposed between the ends thereof, said support means including a portion disposed in snug, slidable, telescopic engagement with said second sleevelike end portion;

releasable detent means coacting between said portion of said support means and said second sleevelike end portion for resisting movement of said cannula means relative to said second vial means;

removable tubular sheath means surrounding said cannula means and extending between said first and second vial means for connecting same together, said sheath means including a first annular end portion having first and second sleevelike parts of different diameters disposed in surrounding relationship to said first sleevelike end portion and said first vial means, respectively, and disposed in snug slidable engagement therewith; said sheath means including a second annular end portion having first and second sleevelike parts of different diameters disposed in surrounding relationship to said second sleevelike end portion and said second vial means, respectively, and disposed in snug slidable engagement therewith, whereby said sheath means can be slidably disconnected from both said first and second vial means;

and

means, including releasable detent means, coacting between said first sleevelike end portion and said sheath means for resisting relative movement of said sheath means toward said first vial means.

2. An assembly according to claim 1, wherein said second vial means has the chamber thereof maintained under a pressure which is substantially below atmospheric pressure.

3. An assembly according to claim 1, wherein said means coacting between said first sleevelike end portion and said sheath means includes an intermediate sleeve member snugly and slidably disposed within the first sleevelike part of said sheath. means, said intermediate sleeve member being slidably disposed on and surrounding said first sleevelike end portion, and said releasable detent means coacting between said first sleevelike end portion and said intermediate sleeve member.

4. An assembly according to claim ll, wherein said first and second sleevelike end portions are of substantially the same diameter, wherein the said first sleevelike part associated with the first annular end portion and the first sleevelike part associated with the second annular end portion are of the same diameter and are connected to one another to form an intermediate tubular portion of uniform diameter, said support means including a sleevelike support member disposed within said intermediate tubular portion and positioned in surrounding relationship to said second sleevelike end portion, and said means coacting between said first sleevelike end portion and said sheath means including an intermediate sleeve member snugly and slidably disposed within the intermediate tubular portion of said sheath means and disposed in surrounding relationship to said first sleevelike end portion. =l

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US2973758 *Dec 27, 1956Mar 7, 1961Invenex PharmaceuticalsApparatus for manufacturing parenteral solutions
US3336924 *Feb 20, 1964Aug 22, 1967SarnoffTwo compartment syringe package
US3368557 *May 24, 1965Feb 13, 1968Novo Terapeutisk Labor AsAmpoule with actuatable cover automatically readying ampoule for injection
US3375825 *Sep 2, 1965Apr 2, 1968Becton Dickinson CoPrefilled syringe
US3392726 *Aug 9, 1965Jul 16, 1968Upjohn CoCombination syringe and vial container
US3563373 *Oct 6, 1967Feb 16, 1971Paulson Paul EHypodermic syringe assembly
US3659602 *Dec 30, 1970May 2, 1972Nosco PlasticsTwo component syringe
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3938518 *Jan 15, 1975Feb 17, 1976Astra Pharmaceutical Products Inc.Syringe attachment device
US3993063 *Jun 16, 1975Nov 23, 1976Union Carbide CorporationProtective shielding assembly for use in loading a hypodermic syringe with radioactive material
US3995630 *Aug 22, 1975Dec 7, 1976U.S. Philips CorporationInjection syringe with telescopic assembly between cartridge and vial
US3999543 *Feb 6, 1976Dec 28, 1976Illinois Tool Works Inc.Medicament additive system
US4161178 *Dec 8, 1977Jul 17, 1979Abbott LaboratoriesAdditive transfer device
US4346820 *May 2, 1980Aug 31, 1982Sigma-Tau Industrie Farmaceutiche RiuniteApparatus for mixing and dispersing two substances under sterile conditions
US4361253 *Aug 4, 1980Nov 30, 1982Instrumentation Laboratory Inc.Liquid transfer device
US4410321 *Apr 6, 1982Oct 18, 1983Baxter Travenol Laboratories, Inc.Closed drug delivery system
US4411662 *Apr 6, 1982Oct 25, 1983Baxter Travenol Laboratories, Inc.Sterile coupling
US4432755 *May 25, 1983Feb 21, 1984Baxter Travenol Laboratories, Inc.Sterile coupling
US4458733 *Apr 6, 1982Jul 10, 1984Baxter Travenol Laboratories, Inc.Mixing apparatus
US4467588 *Apr 6, 1982Aug 28, 1984Baxter Travenol Laboratories, Inc.Separated packaging and sterile processing for liquid-powder mixing
US4484920 *Apr 6, 1982Nov 27, 1984Baxter Travenol Laboratories, Inc.Container for mixing a liquid and a solid
US4573967 *Dec 6, 1983Mar 4, 1986Eli Lilly And CompanyVacuum vial infusion system
US4591049 *Jan 16, 1984May 27, 1986Kidde, Inc.Hermetically sealed two-component mixing system
US4607671 *Aug 21, 1984Aug 26, 1986Baxter Travenol Laboratories, Inc.Reconstitution device
US4619651 *Aug 27, 1984Oct 28, 1986Kopfer Rudolph JAnti-aerosoling drug reconstitution device
US4675020 *Oct 9, 1985Jun 23, 1987Kendall Mcgaw Laboratories, Inc.Connector
US4759756 *Sep 14, 1984Jul 26, 1988Baxter Travenol Laboratories, Inc.Reconstitution device
US4886495 *Jul 8, 1987Dec 12, 1989Duoject Medical Systems Inc.Vial-based prefilled syringe system for one or two component medicaments
US4898209 *Sep 27, 1988Feb 6, 1990Baxter International Inc.Sliding reconstitution device with seal
US4936446 *Feb 28, 1989Jun 26, 1990Laboratoires Merck, Sharp & Dohme-ChibretPackaging and dispensing system for packaging two ingredients separately and mixing them extemporaneously at the time of first use, and method of assembling same
US5088996 *May 18, 1987Feb 18, 1992Kopfer Rudolph JAnti-aerosoling drug reconstitution device
US5117875 *May 25, 1989Jun 2, 1992Piero MarrucchiMethod and device for manipulating and transferring products between confined volumes
US5137511 *Nov 16, 1989Aug 11, 1992Duoject Medical Systems Inc.Syringe
US5176673 *Mar 18, 1991Jan 5, 1993Piero MarrucchiMethod and device for manipulating and transferring products between confined volumes
US5364369 *Nov 14, 1991Nov 15, 1994Reynolds David LSyringe
US5370164 *Sep 14, 1993Dec 6, 1994Galloway CompanyAseptic fluid transfer apparatus and methods
US5445631 *Feb 4, 1994Aug 29, 1995Suntory LimitedFluid delivery system
US5456678 *Mar 28, 1994Oct 10, 1995Nicoletti; PioSafety device for taking samples and performing infusions
US5743312 *Apr 9, 1996Apr 28, 1998Behringwerke AktiengesellschaftComponent mixing apparatus and system including a movable cannula
US5957166 *Jun 16, 1997Sep 28, 1999Fusion Medical Technologies, Inc.Method and apparatus for dispersing fluid into a material
US6021824 *Feb 29, 1996Feb 8, 2000Novo Nordisk A/SKit for storage and mixing of agents of which at least one is liquid
US6132353 *Jul 21, 1997Oct 17, 2000Winkelman; James W.Apparatus and method for separating plasma or serum from the red cells of a blood sample
US6149623 *Jul 13, 1998Nov 21, 2000Duoject Medical Systems Inc.Delivery system for pharmaceuticals packed in pharmaceutical vials
US6378714 *Oct 20, 1999Apr 30, 2002Becton Dickinson And CompanyTransferset for vials and other medical containers
US6398705 *Sep 13, 2000Jun 4, 2002Manfred GrumbergApparatus for separating plasma or serum from the red cells with a blood sample
US6572256 *Oct 7, 2002Jun 3, 2003ImmedicaMulti-component, product handling and delivering system
US6638244 *Sep 25, 2000Oct 28, 2003Duoject Medical Systems Inc.Delivery system for multi-component pharmaceuticals
US6752180 *Sep 6, 2002Jun 22, 2004SedatDevice for the bidirectional transfer of a liquid between a vial and a carpule
US6957745 *Jan 29, 2002Oct 25, 2005Becton, Dickinson And CompanyTransfer set
US7597680 *Feb 8, 2006Oct 6, 2009Kaken Pharmaceutical Co., Ltd.Syringe device and method of preparing medicine using the device
US8007461 *Sep 12, 2006Aug 30, 2011Pingan HuoSterile drug-mixing syringe
US8100154 *Oct 16, 2007Jan 24, 2012Duoject Medical Systems Inc.Reconstitution system for mixing the contents of a vial containing a first substance with a second substance stored in a cartridge
US20120172830 *Sep 8, 2010Jul 5, 2012Terumo Kabushiki KaishaMixing apparatus and piercing method for a double-ended needle
US20140014547 *Mar 27, 2012Jan 16, 2014Terumo Kabushiki KaishaDrug storage container
CN102481228BSep 8, 2010Jul 9, 2014泰尔茂株式会社混合器具及双头针的刺穿方法
DE3510166A1 *Mar 21, 1985Jan 22, 1987Tecnotrans AgUmfuellverschluss fuer chemisch-pharmazeutische substanzen und verfahren zu seiner herstellung
EP0161797A2 *Apr 10, 1985Nov 21, 1985Rudolph J. KopferAnti-aerosoling drug reconstitution device
EP1345566A1 *Dec 6, 2001Sep 24, 2003Technoflex S.A.Re-forming device in particular for mixing substances in the medical field
EP1441842A1 *Oct 7, 2002Aug 4, 2004ImmedicaMulti-component, product handling and delivering system
EP1447072A1 *Feb 13, 2004Aug 18, 2004Becton, Dickinson and CompanyMethod and device for transferring fluids between collection tube holders
WO1983003539A1 *Mar 14, 1983Oct 27, 1983Baxter Travenol LabContainer for mixing a liquid and a solid
WO1983003540A1 *Mar 14, 1983Oct 27, 1983Baxter Travenol LabSterile coupling
WO1983003587A1 *Mar 16, 1983Oct 27, 1983Baxter Travenol LabSeparated packaging and sterile processing for liquid-powder mixing
WO1985004801A1 *Apr 5, 1985Nov 7, 1985Rudolph J KopferAnti-aerosoling drug reconstitution device
WO1986005683A1 *Apr 2, 1986Oct 9, 1986Mediplast AbTransfer device
WO1987002239A1 *Sep 15, 1986Apr 23, 1987Kendall Mcgaw Lab IncConnector
WO1990003536A1 *Sep 14, 1989Apr 5, 1990Baxter IntSliding reconstitution device with seal
WO1996024323A1 *Feb 12, 1996Aug 15, 1996Pharmacia GmbhTransfer device
WO1998017397A1 *Oct 20, 1997Apr 30, 1998Manfred GrumbergApparatus and method for separating blood samples
WO1999038606A1 *Jan 27, 1999Aug 5, 1999Christopher S DauerFluid dispersion and delivery assembly and method
WO2006011751A1 *Jul 27, 2005Feb 2, 2006Kwon Young-DuckPharmaceutical mixing assembly
WO2010052707A1 *Nov 4, 2009May 14, 2010Situ Gen Ltd.Dually activated connector
Classifications
U.S. Classification604/413, 141/329, 206/219
International ClassificationA61J1/14, A61J1/20, A61J1/00
Cooperative ClassificationA61J2001/2013, A61J2001/2065, A61J1/2089
European ClassificationA61J1/20B